Dexamethasone or cyclosporin A inhibits stem cell factor-dependent secretory responses of rat peritoneal mast cells in vitro

Immunopharmacology

Volumn 34, Issue 1, 1996, Pages 63-70

  Taylor, Ailsa M ^a   Galli, Stephen J ^b   Coleman, John W ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Cyclosporin A; Dexamethasone; Mast cell; Mediator release; Stem cell factor

Indexed keywords

CYCLOSPORIN A; DEXAMETHASONE; FC RECEPTOR; IMMUNOGLOBULIN E; SEROTONIN; STEM CELL FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; FEMALE; FLOW CYTOMETRY; MAST CELL; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL; RAT;

EID: 0030220180     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/0162-3109(96)00109-9     Document Type: Article

References (40)

1. Amon EU. Cyclosporine A inhibits histamine release from human peripheral basophils and human skin mast cells. Agents Actions 1992; C250-C252.
2. Aridor M, Traub LM, Sagi-Eisenberg R. (1990) Exocytosis in mast cells by basic secretagogues - evidence for direct activation of GTP-binding proteins. J. Cell Biochem. 1990; 111: 909-917.
3. 13. Science 1993; 262: 1569-1572.
4. Bischoff SC, Dahinden CA, c-kit ligand - a unique potentiator of mediator release from by human mast cells. J. Exp. Med. 1992; 175: 237-244.
5. Burd PA, Rogers HW, Gordon JR, Martin CA, Jayaraman S, Wilson SD, Dvorak AM, Galli SJ, Dorf ME. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J. Exp. Med. 1989; 170: 245-257.
6. Casolaro V, Spadaro G, Patella V, Marone G. In vivo characterization of the anti-inflammatory effect of cyclosporin A on human basophils. J. Immunol. 1993; 151: 5563-5573.
7. Cohan VL, Undem BJ, Fox CC, Adkinson NF, Lichtenstein LM, Schleimer RP. Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine or skin. Am. Rev. Resp. Dis. 1989; 140: 951-954.
8. Coleman JW, Holliday MR, Kimber I, Zsebo KM, Galli SJ. Regulation of mouse peritoneal mast cell secretory function by stem cell factor. IL-3 or IL-4. J. Immunol. 1993; 150: 556-562.
9. Collado-Escobar D, Cunha-Melo JR, Beaven MA. Treatment with dexamethasone down-regulates IgE-receptor-mediated signals and up-regulates adenosine-reeeptor-mediated signals in a rat mast cell (RBL-2H3) line. J. Immunol. 1990; 144: 244-250.
10. Columbo M, Horowitz EM, Botana LM, MacGlashan DW, Bochner BS, Gillis S, Zsebo KM, Galli SJ, Lichtenstein LM. The human recombinant c-kit receptor ligand. rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J. Immunol. 1992; 149: 599-608.
11. Daeron M, Sterk AR, Hirata F, Ishizaka T. Biochemical analysis of glucocorticoid-induced inhibition of IgE-mediated histamine release from mouse mast cells. J. Invest. Dermatol. 1982; 129: 1212-1218.
12. DePaulis A, Ciccarelli A, Cirillo R, Decrescenzo G, Columbo M, Marone M, Marone G. Modulation of human lung mast cell function by the the c-kit receptor ligand. Int. Arch. Allergy Immunol 1992; 99: 326-329.
13. Dráberová L. Cyclosporin A inhibits rat mast cell activation. Eur. J. Immunol. 1990; 20: 1469-1473.
14. Foreman JC, Mongar JL, Gomperts BD. Calcium ionophores and the movement of calcium ions following the physiological stimulus to a secretory process. Nature 1973; 245: 249-251.
15. GaIIi SJ, Tsai M, Langley KE, Zsebo KM, Geissler EN. Stem cell factor (SCF), a ligand for c-kit, induces mediator release from some populations of mouse mast cells. FASEB. J. 1991; 5: A1092.
16. Galli SJ, Iemura A, Garlick DS, Gamba-Vitalo C, Zsebo KM, Andrews RG. Reversible expansion of primate mast cell populations in vivo by stem cell factor. J. Clin. Invest. 1993; 91: 148-152.
17. Gurish MF, Ghildyal N, McNeil HP, Austen KF, Gillis S, Stevens RL. Differential expression of secretory granule proteases in mouse mast cells exposed to interleukin 3 and c-kit ligand. J. Exp. Med. 1992; 175: 1003-1012.
18. Hatfield SM and Roehm NW. Cyclosporine and FK506 inhibition of murine mast cell cytokine production. J. Pharm. Exp. Ther. 1992; 260: 680-688.
19. Heiman AS, Crews FT. Inhibition of immunoglobulin but not polypeptide base-stimulated release of histamine and arachadonic acid by anti-inflammatory steroids. J. Pharm. Exp. Ther. 1984; 230: 175-182.
20. Irani A-MA, Nilsson G, Miettinen U, Craig SS, Ashman LK, Ishizaka T, Zsebo KM, Schwanz LB. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 1992; 80: 3009-3021.
21. Irani AA, Nilsson G, Ashman LK, Schwartz LB. Dexamethasone inhibits the development of mast cells from dispersed human fetal liver cells cultured in the presence of recombinant human stem cell factor. Immunology 1995; 84: 72-78.
22. Kaye RE, Fruman DA, Bierer BE, Albers MW, Zydowsky LD, Ho SI, Jin YJ, Castells MC, Schreiber SL, Walsh CT, Burakoff SJ, Austen KF, Katz HR. Effects of cyclosporin A on Fc-epsilon receptor type-I-initiated increases in cytokine messenger RNA in mouse bone marrow derived progenitor mast cells - resistance to FK506 is associated with a deficiency in FK506-binding protein FKBP12. Proc. Natl. Acad. Sci. USA 1992; 89; 8542-8546.
23. Leal-Berumen I, Conlon P, Marshall JS. 1L-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. J. Immunol. 1994; 152: 5468-5476.
24. Lewis GP, Whittle BJR. The inhibition of histamine release from rat peritoneal mast cells by non-steroid anti-inflammatory drugs and its reversal by calcium. Brit. J. Pharmacol. 1977; 61: 229-235.
25. Nakajima K, Hirai K, Yamaguchi M, Takeishi T, Ohta K, Morita Y, Ito K. Stem cell factor has histamine releasing activity in rat connective tissue-type mast cells. Biochem. Biophys. Res. Comm. 1992; 183: 1076-1083.
26. Robin J-L., Seldin DC, Austen KF, Lewis RA. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids. J. Immunol, 1985; 135: 2719-2726.
27. Schleimer RP, Lichtenstein LM, Gillespie E. Inhibition of basophil histamine release by anti-inflammatory steroids. Nature 1981; 292: 454-455.
28. Schleimer RP, MacGlashan DW Jr, Gillespie E, Lichtenstein LM. Inhibition of basophil histamine release by anti-inflammatory steroids. II. Studies on the mechanism of action. J. Immunol. 1982; 129: 1632-1636.
29. Schleimer RP, Schulman ES, MacGlashan DW Jr, Peters SP, Hayes EC, Adams GK III, Lichtenstein LM, Adkinson NF. Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. J. Clin. Invest. 1983; 71: 1830-1835.
30. Stellato C, DePaulis A, Ciccarelli A, Ciriollo R, Patella V, Casolaro V, Marone G. Anti-inflammatory effect of cyclosporin A on human skin mast cells. J. Invest. Dermatol. 1992; 98: 800-804.
31. Taylor AM, Galli SJ, Coleman JW. Stem-cell factor, the kit ligand, induces direct degranulation of rat peritoneal mast cells in vitro and in vivo: dependence of the in vitro effect on period of culture and comparisons of stem cell factor with other mast cell-activating agents. Immunology 1995; 86: 427-433.
32. Tsai M, Shih L-S, Newlands GFJ, Takeishi T, Langley KE, Zsebo KM, Miller HRP, Geissler EN, Galli SJ. The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype. J. Exp. Med. 1991; 174: 125-131.
33. Tsai M, Tam S-Y, Galli SJ. Distinct patterns of early response gene expression and proliferation in mouse mast cells stimulated by stem cell factor, interleukin-3, or IgE and antigen. Eur. J. Immunol. 1993a; 23: 867-872.
34. rsk and pp70-S6 kinases in mouse mast cells by signalling through the c-kit tyrosine or Fc∈RI: rapamycin inhibits activation of pp70-S6 kinase and proliferation in mouse mast cells. Eur. J. Immunol. 1993b; 23: 3286-3291.
35. Tsuji K, Zsebo KM, Ogawa M. Murine mast cell colony formation supported by IL-3, IL-4 and recombinant rat stem cell factor, ligand for c-kit. J. Cell Physiol. 1991; 148: 362-369.
36. Ulieh TR, del Castillo J, Yi ES, Yin S, McNiece I, Yung YP, Zsebo KM. Hematologic effects of stem cell factor in vivo and in vitro in rodents. Blood 1991; 78: 645-650.
37. Valent P. Spanblöchl E, Sperr WR, Sillaber C, Zsebo KM, AgisH, Strobl H, Geissler K, Bettelheim P, Eechner K. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long term culture. Blood 1992; 80: 2237-2245.
38. Wershil BK, Tsai M, Geissler EN, Zsebo KM, Galli SJ. The rat c-kit ligand, stem cell factor, induces c-kit receptor-dependent mouse mast cell activation in vivo, evidence that signalling through the c-kit receptor can induce expression of cellular function. J. Exp. Med. 1992; 175: 245-255.
39. Wershil BK, Furuta GT, Lavigne JA, Choudhury AR, Wang ZS, Galli SJ. Dexamethasone or cyclosporine A suppresses mast cell leucocyte cytokine cascades - multiple mechanisms of inhibition of IgE-dependent and mast cell-dependent cutaneous inflammation in the mouse. J. Immunol. 1995; 154: 1391-1398.
40. Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, Hsu R, Birkett NC, Okino KH, Murdock DC, Jacobsen FW, Langley KE, Smith KA, Takeishi T, Cattanach BM, Galli SJ, Suggs SV. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 1990; 63: 213-224.